NASDAQ-NMS:SNDL

SNDL Completes Acquisition of The Valens Company

Retrieved on: 
Tuesday, January 17, 2023

CALGARY, AB, Jan. 17, 2023 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" the "Company") is pleased to announce the completion of the previously disclosed acquisition of all of the issued and outstanding common shares ("Valens Shares") of The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) ("Valens"), other than those held by SNDL and its subsidiaries, pursuant to a plan of arrangement under the Canada Business Corporations Act (the "Transaction"), for total consideration of approximately $138 million2 consisting of common shares of SNDL ("SNDL Shares") and assumption of Valens' $60 million non-revolving term loan facility.

Key Points: 
  • CALGARY, AB, Jan. 17, 2023 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" the "Company") is pleased to announce the completion of the previously disclosed acquisition of all of the issued and outstanding common shares ("Valens Shares") of The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) ("Valens"), other than those held by SNDL and its subsidiaries, pursuant to a plan of arrangement under the Canada Business Corporations Act (the "Transaction"), for total consideration of approximately $138 million2 consisting of common shares of SNDL ("SNDL Shares") and assumption of Valens' $60 million non-revolving term loan facility.
  • Valens Shareholders to participate in and help create the future of SNDL: Valens Shareholders are to receive SNDL common shares in an all-stock transaction.
  • Pursuant to the Transaction, former holders of Valens Shares ("Valens Shareholders"), received from SNDL, in exchange for each Valens Share held, 0.3334 of a common share (each whole share, a "SNDL Share") of SNDL (the "Consideration").
  • Following the closing of the Transaction, there are 260.7 million SNDL Shares outstanding, with existing SNDL Shareholders holding approximately 89.4% of such outstanding SNDL Shares and former Valens Shareholders holding approximately 10.6% of such outstanding SNDL Shares.

THE VALENS COMPANY OBTAINS FINAL COURT ORDER APPROVING THE PROPOSED PLAN OF ARRANGEMENT WITH SNDL

Retrieved on: 
Tuesday, January 3, 2023

Under the terms of the Arrangement, Valens' shareholders will receive, for each common share of Valens (each, a "Valens Share"), 0.3334 of a common share of SNDL (the "Offer Exchange Ratio").

Key Points: 
  • Under the terms of the Arrangement, Valens' shareholders will receive, for each common share of Valens (each, a "Valens Share"), 0.3334 of a common share of SNDL (the "Offer Exchange Ratio").
  • The Valens Company is a leading cannabis consumer products company, with significant expertise in manufacturing cannabinoid-based products and a mission to bring the benefits of cannabis to the world.
  • Specific forward-looking statements include, without limitation, statements regarding the anticipated timing for completion of the proposed plan of arrangement involving The Valens Company and SNDL.
  • The risks and uncertainties that may affect forward-looking statements include, among others, if and when the proposed plan of arrangement involving The Valens Company and SNDL.

SNDL and Nova Cannabis Announce Transformational Strategic Partnership Creating a Sustainable Canadian Cannabis Retail Platform

Retrieved on: 
Wednesday, December 21, 2022

Nova will also have a right of first refusal on SNDL's Canadian cannabis retail pipeline.

Key Points: 
  • Nova will also have a right of first refusal on SNDL's Canadian cannabis retail pipeline.
  • Increased Liquidity: SNDL plans to reduce its equity ownership in Nova to below 20% through a capital distribution of Nova Shares owned by SNDL to SNDL shareholders.
  • Creates sustainable regulated retail network in Canada: The Agreement provides a low-cost operating platform for Nova, driven by SNDL's scale across cannabis and alcohol.
  • Pure-play retail exposure for SNDL shareholders: A share capital distribution of Nova Shares provides SNDL shareholders the optionality of equity exposure to a well-capitalized Canadian retail platform.

High Tide Becomes Top Revenue-Generating Cannabis Company in Canada

Retrieved on: 
Tuesday, November 22, 2022

According to New Cannabis Ventures, we are now the highest Canadian revenue-generating cannabis company across all three verticals of retail, extraction and growing.

Key Points: 
  • According to New Cannabis Ventures, we are now the highest Canadian revenue-generating cannabis company across all three verticals of retail, extraction and growing.
  • This opening marks High Tide's 142nd Canna Cabana branded retail cannabis location in Canada and is the 44th location in Ontario.
  • In addition, High Tide announces the grant of an aggregate of 15,000 incentive stock options (the "Options") to certain employees of the Company.
  • High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets.

SNDL to Announce Third Quarter 2022 Financial Results on November 14, 2022

Retrieved on: 
Friday, October 28, 2022

To access the replay, dial:

Key Points: 
  • To access the replay, dial:
    The webcast archive will be available for three months via the link provided above.
  • SNDL is the largest private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf.
  • SNDL is a licensed cannabis producer that uses state-of-the-art indoor facilities to supply wholesale and retail customers under a cannabis brand portfolio that includes Top Leaf, Sundial Cannabis, Palmetto, Spiritleaf Selects, and Grasslands.
  • SNDL's investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the global cannabis industry.

SNDL and IM Cannabis Complete SNDL's First International Export of Premium Dried Flower from Canada to Israel

Retrieved on: 
Thursday, September 15, 2022

SNDL and IMC have agreed to the aggregate export of 1,000 kilograms of high-quality dried flower products for processing and distribution in the Israeli medical cannabis market.

Key Points: 
  • SNDL and IMC have agreed to the aggregate export of 1,000 kilograms of high-quality dried flower products for processing and distribution in the Israeli medical cannabis market.
  • "SNDL plans to opportunistically expand the Company's premium inhalables footprint to international cannabis markets, and this initial endeavour strengthens our pursuits in both established medical markets and emerging global recreational markets."
  • For IMC, the completed export marks another major step forward in streamlining its expansive global operations that include Israel, Canada, and Germany.
  • "The medical cannabis market in Israel has shifted towards premium and ultra-premium cannabis products.

Thinking about buying stock in Windtree Therapeutics, Helius Medical Technologies, SNDL, Xpeng, or Indonesia Energy?

Retrieved on: 
Tuesday, August 23, 2022

Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.

Key Points: 
  • Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.
  • Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
  • InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street.
  • We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

SNDL Announces Agreement to Acquire The Valens Company to Create Leading Vertically Integrated Cannabis Platform

Retrieved on: 
Monday, August 22, 2022

CALGARY, AB and KELOWNA, BC, Aug. 22, 2022 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL") and The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) ("Valens") are pleased to announce today that they have entered into an arrangement agreement (the "Agreement") to combine their businesses and create a leading vertically integrated cannabis platform.

Key Points: 
  • CALGARY, AB and KELOWNA, BC, Aug. 22, 2022 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL") and The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) ("Valens") are pleased to announce today that they have entered into an arrangement agreement (the "Agreement") to combine their businesses and create a leading vertically integrated cannabis platform.
  • The combined company will operate as SNDL Inc., and Valens shareholders will own approximately 9.5% of the pro forma entity.
  • Valens shareholders to participate in and help create the future of SNDL: Valens shareholders are to receive SNDL common shares in an all-stock transaction.
  • The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world.

SNDL to Announce Second Quarter 2022 Financial Results on August 12, 2022

Retrieved on: 
Tuesday, August 2, 2022

To access the replay, dial:

Key Points: 
  • To access the replay, dial:
    The webcast archive will be available for three months via the link provided above.
  • SNDL is a public company whose shares are traded on Nasdaq under the symbol "SNDL."
  • Its business is operated and reported in four segments: Liquor Retail, Cannabis Retail, Cannabis Production and Cultivation, and Investments.
  • SNDL's investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the global cannabis industry.